UNITEDHEALTH GROUP INCORPORATED (Delaware) financials
$374.94−0.76%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $112.03B | $110.59B | $113.22B | $113.16B | $111.62B | $108.54B | $100.81B | $100.82B | $98.86B | $99.80B | $94.43B | $92.36B |
| Gross profit | $36.67B | $37.10B | $31.17B | $33.20B | $33.03B | $35.13B | $33.77B | $34.86B | $33.40B | $34.06B | $32.20B | $32.81B |
| Gross margin | 32.7% | 33.5% | 27.5% | 29.3% | 29.6% | 32.4% | 33.5% | 34.6% | 33.8% | 34.1% | 34.1% | 35.5% |
| Operating income | $7.99B | $7.86B | $380.0M | $4.32B | $5.15B | $8.09B | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B | $8.53B |
| Net income | $5.48B | $6.28B | $10.0M | $2.35B | $3.41B | $6.29B | $5.54B | $6.05B | $4.22B | -$1.41B | $5.46B | $5.84B |
| Net margin | 4.9% | 5.7% | 0.0% | 2.1% | 3.1% | 5.8% | 5.5% | 6.0% | 4.3% | −1.4% | 5.8% | 6.3% |
| Diluted EPS | $6.04 | $6.90 | $0.01 | $2.59 | $3.74 | $6.85 | $5.92 | $6.51 | $4.54 | $-1.53 | $5.85 | $6.24 |
| EBITDA | $9.03B | $8.89B | $1.50B | $5.41B | $6.23B | $9.15B | $8.81B | $9.75B | $8.89B | $8.93B | $7.69B | $9.53B |
| Operating cash flow | $11.05B | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | -$5.19B | $6.90B |
| Free cash flow | $10.25B | $8.15B | $160.0M | $5.05B | $6.30B | $4.56B | $1.46B | $12.95B | $5.89B | $401.0M | -$6.15B | $6.06B |
| Diluted shares | 906.0M | 910.0M | 908.0M | 908.0M | 910.0M | 918.0M | 936.0M | 930.0M | 928.0M | 922.0M | 933.0M | 936.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $73.33B | $77.92B | $78.39B | $80.14B | $79.19B | $81.27B |
| Total assets | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B |
| Total liabilities | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B |
| Shareholders' equity | $105.95B | $103.89B | $101.70B | $105.81B | $104.78B | $105.17B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology